QCLS

What one share of Q/C Technologies holds

In Vitro and In Vivo Diagnostic Substances

Q/C Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Profit−$3.19
Cash and investments$1.34
Book value$1.96

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2021—−$2,484————
2022—−$1,139————
2023—−$516.81————
2024—−$1,081————
2025—−$8.66$1.01−$6.25—$2.83

Common questions about Q/C Technologies

How much does one share of Q/C Technologies earn?

Over the last 12 months, Q/C Technologies lost $3.19 for each share.

Does Q/C Technologies pay a dividend?

Q/C Technologies didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Q/C Technologies’s book value per share?

Q/C Technologies’s book value is $1.96 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Q/C Technologies have?

Each share of Q/C Technologies has $1.34 of cash and investments, as of June 30, 2026.

Has Q/C Technologies bought back shares?

Q/C Technologies’s share count rose about 14276% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.